The global external urine management products market size was valued at USD 544.72 million in 2021 and is projected to reach USD 844.37 million by 2030, growing at a CAGR of 5.09% from 2022 to 2030.  One of the primary factors driving this growth is the increasing aging population worldwide, as age-related changes in urinary function create a higher demand for effective urine management solutions.

As people age, they often experience several physiological changes in the lower urinary system. Among elderly men, this may include prostate gland enlargement, while both men and women face issues such as reduced bladder capacity, diminished sensation of fullness, decreased pelvic floor muscle resistance, weakened detrusor muscle contraction, and higher residual urine volume. These changes frequently result in bladder control problems, such as urinary leakage, incontinence (UI), or retention, which significantly affect quality of life and necessitate the use of external urine management products.

According to the American Society of Nephrology, urologic diseases are ranked as the third-most common health concern among the elderly, accounting for approximately 47.0% of physician visits. This high prevalence of urinary issues, coupled with growing awareness initiatives led by governments and non-profit organizations, has been pivotal in boosting demand. Furthermore, rising technological investments in product development—such as improvements in comfort, absorbency, and skin protection—are also contributing to market growth by offering patients more effective and user-friendly solutions.

The COVID-19 pandemic further accelerated demand for urine management products, particularly in hospital settings. With the elderly population being highly vulnerable due to weakened immunity, hospital admission rates surged globally during the outbreak. As a result, the use of external urine management products became increasingly important in hospitals to ensure effective patient care, infection control, and overall comfort for long-term and critically ill patients.

Key Market Trends & Insights:

In 2021, North America emerged as the leading region in the global external urine management products market, capturing a revenue share of over 39.68%. This dominance can be attributed to several factors, including a large aging population, higher awareness about urinary incontinence management, strong healthcare infrastructure, and the availability of advanced products. Additionally, supportive reimbursement policies and widespread adoption of innovative urine management solutions further reinforced the region’s market leadership.

Based on product type, the male external catheters segment held the dominant position in 2021. These products are widely used due to their non-invasive nature, ease of application, and effectiveness in managing urinary incontinence in men, particularly among the elderly. Their growing adoption in both hospital and homecare settings highlights their importance in improving patient comfort and reducing complications associated with traditional indwelling catheters.

By distribution channel, the offline segment accounted for the largest share, exceeding 57.10% in 2021. Pharmacies, medical supply stores, and hospital procurement remain the preferred sources for external urine management products, as they allow patients and caregivers to access a wide range of options with professional guidance. The strong presence of offline retail networks, combined with trust in direct product availability, continues to make this channel the most dominant despite the growing penetration of online platforms.

In terms of end-use, the hospital segment dominated the market in 2021, representing more than 43.00% of the global share. Hospitals remain the primary setting for the use of external urine management products, as they cater to a high number of elderly and critically ill patients who require effective and hygienic solutions for urinary incontinence or retention. The increasing rate of hospital admissions, coupled with the growing need for infection control and patient comfort, has further driven the adoption of these products in hospital environments.

Order a free sample PDF of the External Urine Management Products Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

• 2021 Market Size: USD 544.72 Million

• 2030 Projected Market Size: USD 844.37 Million

• CAGR (2022-2030): 5.09%

• North America: Largest market in 2021

Key Companies & Market Share Insights:

Companies operating in the external urine management products market are increasingly adopting comprehensive growth strategies to strengthen their market presence and improve product accessibility. These strategies include enhancing product differentiation, diversifying product portfolios, expanding marketing and distribution networks, and establishing strategic collaborations or alliances. By leveraging these approaches, companies aim to reach a wider customer base, address varied patient needs, and secure a stronger competitive advantage in a highly dynamic market.

To further solidify their market position, key players are also relying on acquisitions, mergers, partnerships, and frequent new product launches. These initiatives not only help them expand geographically but also enable access to advanced technologies and broadened product offerings.

For example, in February 2019, Coloplast entered into a three-year agreement with Premier, Inc., a U.S.-based healthcare improvement company, for the supply of its urology products. This collaboration reflects the company’s commitment to expanding its distribution capabilities and improving the availability of its specialized healthcare solutions in the U.S. market.

Similarly, in June 2020, B. Braun Melsungen AG introduced virtual support services (Emerald Nursing Service) during the COVID-19 pandemic to provide better care for vulnerable patients dealing with acute bladder problems at home. This innovative service offered continence and ostomy care products directly to patients, supported by FaceTime video tutorials and professional advice, thereby ensuring continuity of care despite restrictions on hospital visits. By integrating digital tools with product delivery, the company enhanced patient engagement and created a more resilient distribution channel during a challenging period.

Key Players

• Hollister Inc.

• Sage Products LC (Stryker)

• BD (C. R. Bard)

• Teleflex Inc.

• Consure Medical

• Tilla Care Inc.

• B. Braun Melsungen AG

• Boehringer Laboratories, LLC

• Men’s Liberty (BioDerm)

• Coloplast Corp.

• Sterimed Group

• Cardinal Health

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The market for external urine management products is expected to grow steadily. Aging populations, higher incidence of urinary incontinence and related urological concerns, and increasing awareness efforts by both governments and non-profit groups are primary forces behind rising demand. Hospitals and healthcare settings remain key consumers, and growth is further supported by the push toward long-term solutions and improved product delivery (including home care). Meanwhile, online distribution channels and innovations in product design/features are helping companies reach more users and respond to evolving needs.